Molecular Relapse After a Second Treatment-Free Remission Attempt Following Asciminib in Chronic Myeloid Leukemia: A Case Report
Treatment-free remission (TFR) has become an important therapeutic goal in chronic myeloid leukemia (CML). Although the outcomes of TFR following adenosine triphosphate (ATP)–competitive tyrosine kinase inhibitors (TKIs) have been established, data on TFR after asciminib discontinuation remain limit...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley
2026-01-01
|
| coleção: | Case Reports in Hematology |
| Acesso em linha: | http://dx.doi.org/10.1155/crh/1621284 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|